Conclusive evidence of the disease-relevance of GEMINs requires functional assessment in SMA animal models, particularly a positive impact on neuromuscular defects and life expectancy on augmentation of their function in an SMN deficient backdrop. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.